Randomised clinical trial: the efficacy of prucalopride in patients with chronic intestinal pseudo-obstruction--a double-blind, placebo-controlled, cross-over, multiple n = 1 study - Wikidata - wikimedia - TriplyDB

Randomised clinical trial: the efficacy of prucalopride in patients with chronic intestinal pseudo-obstruction--a double-blind, placebo-controlled, cross-over, multiple n = 1 study

Randomised clinical trial: the efficacy of prucalopride in patients with chronic intestinal pseudo-obstruction--a double-blind, placebo-controlled, cross-over, multiple n = 1 study

http://www.wikidata.org/entity/Q34230555

about

Review article: the assessment and management of chronic severe gastrointestinal dysmotility in adults Prucalopride for chronic intestinal pseudo-obstruction Chronic intestinal pseudo-obstruction Current management of the gastrointestinal complications of systemic sclerosis.Prucalopride for the treatment of ileus.The effects of prucalopride on postoperative ileus in guinea pigs.Management Strategies for Abdominal Bloating and Distension.Prucalopride: evaluation of the pharmacokinetics, pharmacodynamics, efficacy and safety in the treatment of chronic constipation.New perspectives in the diagnosis and management of enteric neuropathies.Prucalopride: a review of its use in the management of chronic constipation.New pharmacological treatment options for chronic constipation.Metabolic kinetics of 5-hydroxytryptamine and the research targets of functional gastrointestinal disorders.Advancement in the clinical management of intestinal pseudo-obstruction.Efficacy and safety of prucalopride in adults and children with chronic constipation.Prucalopride: For functional constipation only?Chronic intestinal pseudo-obstruction in children and adults: diagnosis and therapeutic options.Influence of a new 5-HT4 receptor partial agonist, YKP10811, on visceral hypersensitivity in rats triggered by stress and inflammation.Long-term outcome of prucalopride for chronic constipation: a single-centre study.An update on prucalopride in the treatment of chronic constipation.Chronic intestinal pseudo-obstruction: Progress in management?Recent advances in understanding and managing chronic constipation

P2860

Q27030666-0CD73FCE-0702-4963-9E96-B282B0F20614 Q28256752-3480D034-976A-445C-9302-C4E0F87DB420 Q28289526-C8FA5BCF-458B-435E-A43E-4602FBA58BBC Q36068493-06A99C66-ADF6-4000-9B80-702C950093F8 Q36302121-E7505786-1F68-42AE-A2D8-173DD224FA60 Q36872925-6B3D6B9D-E3F6-4A3C-8D2B-99D14C3FBA7A Q37190545-EBAC56D5-7DD2-45D8-9E4B-BD18965F4D95 Q38044067-7B248E30-662B-46B0-BDB6-354985CC6BC0 Q38080664-79FAB09D-FB76-4315-9E47-27754FE8FBC1 Q38160205-0795AF82-79E8-4E38-A5F6-AA5BA27BCF62 Q38198743-FD282F1D-D59F-4E77-9EF5-46F884E449A0 Q38219316-5BF92096-C29E-4BD5-BCE6-9D6739BFF646 Q38229131-136331E7-264F-4E43-9C80-A26CBF55200A Q38300258-2F869F0F-756E-4418-ACF2-E39A64DF1E9C Q38833279-CDB62BFD-EB41-455C-B9F8-634249EC1C1F Q38967384-258C3561-7087-4FB1-A088-9394A5E23B23 Q42703872-FC7E1DF7-F752-4352-99D1-6DB1CA61B43C Q43332981-945A4B27-9970-4399-A78F-B98C2ADB488C Q45044943-937A3672-FE1A-4DFD-A98E-A67D7278AE5F Q47588184-56F5E192-DB40-4383-BC47-0E73DC3818A8 Q58562464-92C421FC-2F34-43DC-89BE-209E811D1F80

P2860

Randomised clinical trial: the efficacy of prucalopride in patients with chronic intestinal pseudo-obstruction--a double-blind, placebo-controlled, cross-over, multiple n = 1 study

http://www.wikidata.org/entity/Q34230555

description

2011 nî lūn-bûn

@nan

2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Randomised clinical trial: the ...... oss-over, multiple n = 1 study

@ast

Randomised clinical trial: the ...... oss-over, multiple n = 1 study

@en

Randomised clinical trial: the ...... oss-over, multiple n = 1 study

@nl

type

label

Randomised clinical trial: the ...... oss-over, multiple n = 1 study

@ast

Randomised clinical trial: the ...... oss-over, multiple n = 1 study

@en

Randomised clinical trial: the ...... oss-over, multiple n = 1 study

@nl

prefLabel

Randomised clinical trial: the ...... oss-over, multiple n = 1 study

@ast

Randomised clinical trial: the ...... oss-over, multiple n = 1 study

@en

Randomised clinical trial: the ...... oss-over, multiple n = 1 study

@nl

P1433

Q34230555-D64B0F96-4F35-49E6-8D19-590B5E7E5582

P1476

Q34230555-0F885BEE-E93F-4580-B3E3-74DB9E5938D9

P2093

Q34230555-080B28FE-8969-4BBA-96E4-4A725DB15E32

Q34230555-4AF99BB6-4384-4DE7-A6E9-82014242DE9A

Q34230555-5D6176E6-6794-4067-9C34-8EEB615121EA

Q34230555-78056621-ABF5-418C-B4EC-87CE33773B38

Q34230555-EB4CE216-CD54-4FB8-8936-48BF7D67268A

P2860

Q34230555-07FA37FB-A336-45DE-A24E-03AB8E560DFF

Q34230555-08091469-ADBC-433A-80EF-8A226E402EEA

Q34230555-1F1E9EEF-76C0-458F-8F5A-E0F9A898C774

Q34230555-2C237ED4-20FC-46D9-8ED7-F3D2852D84E8

Q34230555-6A40C357-5450-4491-91D9-B898E427BBC9

Q34230555-6BC982F0-9495-4150-9BDE-3684E6E77407

Q34230555-74E4C54B-07C7-40D8-9420-A389980FCCB3

Q34230555-78178710-16D3-4B6A-B243-9D2AF20D01DB

Q34230555-97818C7F-D5AC-46FB-B956-52CFF94CEB95

Q34230555-9DF266F0-8B9D-47E5-BF35-09BA98CB898B

P304

Q34230555-EDB78DD0-5106-4DDF-B0DB-3D20D57BB9C2

P31

Q34230555-03A511BF-F27C-42F3-A37E-7FE8D7581229

P356

Q34230555-E9D32838-BC8D-4AA6-A3DF-9ED039EC7BFA

P407

Q34230555-C1030BBF-FAFC-4672-B905-54654C23B27D

P433

Q34230555-654A3BFD-AB11-4D09-A11D-5FE9316CF725

P478

Q34230555-90401180-DBE6-42CD-954F-4484E6B5D78E

P577

Q34230555-01C11EED-E0CA-4D7A-888D-39D07A34FD40

P5875

Q34230555-B3C9D10F-F00B-4D39-8473-6FAAA81F70B8

P698

Q34230555-25BB9C03-3048-4852-9462-E94508C9FAF4

P921

Q34230555-0DB5BFE1-4874-4B38-A534-AF9FB483D1B1

Q34230555-113161BF-6F30-437E-9365-55120423C8E3

Q34230555-65E6B6DE-C25A-4BEA-8647-FC56D425B0C4

P932

Q34230555-8C9AB93C-B2CF-40F2-B6EE-5B4C6F27829A

P356

J.1365-2036.2011.04907.X

P1433

Alimentary Pharmacology & Therapeutics

P1476

Randomised clinical trial: the ...... oss-over, multiple n = 1 study

@en

P2093

A J Roy

http://www.w3.org/2001/XMLSchema#string

A V Emmanuel

http://www.w3.org/2001/XMLSchema#string

L Vandeplassche

http://www.w3.org/2001/XMLSchema#string

M A Kamm

http://www.w3.org/2001/XMLSchema#string

R Kerstens

http://www.w3.org/2001/XMLSchema#string

P2860

Prucalopride accelerates gastrointestinal and colonic transit in patients with constipation without a rectal evacuation disorder.

Selective stimulation of colonic transit by the benzofuran 5HT4 agonist, prucalopride, in healthy humans.

The in vitro pharmacological profile of prucalopride, a novel enterokinetic compound.

5-HT4 receptor agonists: similar but not the same.

A placebo-controlled trial of prucalopride for severe chronic constipation.

Prucalopride (Resolor) in the treatment of severe chronic constipation in patients dissatisfied with laxatives.

Clinical trial: the efficacy, impact on quality of life, and safety and tolerability of prucalopride in severe chronic constipation--a 12-week, randomized, double-blind, placebo-controlled study.

Deranged smooth muscle alpha-actin as a biomarker of intestinal pseudo-obstruction: a controlled multinational case series.

Clinical characteristics of chronic idiopathic intestinal pseudo-obstruction in adults

Review article: abdominal bloating and distension in functional gastrointestinal disorders--epidemiology and exploration of possible mechanisms.

P304

48-55

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-2036.2011.04907.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

35

http://www.w3.org/2001/XMLSchema#string

P577

2011-11-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51781531

http://www.w3.org/2001/XMLSchema#string

P698

22061077

http://www.w3.org/2001/XMLSchema#string

P921

Chronic intestinal pseudo-obstruction

P932

3298655

http://www.w3.org/2001/XMLSchema#string